Results

1–7 of 7 results for Amy C. Schefler

Phase 2 Trial of Belzupacap Sarotalocan (Bel-Sar, AU-011), a Targeted Therapy for Choroidal Melanoma via Suprachoroidal Administration
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2023
Prospective Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: One-Year Outcomes
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2022
Comparison of Tumor Size at Presentation and Genomics in Uveal Melanoma Patients Before and After the COVID-19 Pandemic
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2021
Two-Year Results of an Ongoing Phase 1b/2 Open-Label Clinical Trial of AU-011 for the Primary Treatment of Small to Medium Choroidal Melanoma
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2019
6-Month Results of a Phase 1b-2 Prospective Multicenter Clinical Trial of a Novel Targeted Therapy (AU-011) for the Treatment of Choroidal Melanoma
Amy C. Schefler, MD FACS FASRS
Annual Meeting Talks
2018
Part 2: Vitreous, Retina, and Choroidal Biopsies: Surgical and Pathologic Techniques, Commercial Options for Analyses, and Update on Recent Studies
Amy C. Schefler, MD FACS FASRS
Prithvi Mruthyunjaya, MD, MHS
Thomas M. Aaberg Jr. , MD
Zelia M. Correa, MD, PhD
Ivana K. Kim, MD
On Demand Cases, Courses, and Papers
2017
Part 1: Vitreous, Retina, and Choroidal Biopsies: Surgical and Pathologic Techniques, Commercial Options for Analyses, and Update on Recent Studies
Amy C. Schefler, MD FACS FASRS
Prithvi Mruthyunjaya, MD, MHS
Thomas M. Aaberg Jr. , MD
Zelia M. Correa, MD, PhD
Ivana K. Kim, MD
On Demand Cases, Courses, and Papers
2017